Therefore, ZCyd was able to inhibit the epigenetic silencing of VDR and restore calcitriol sensitivity of breast cancer cell lines, thus representing a potential drug in anti-cancer therapy [35]. This evidence concerns the gene VDR and breast carcinoma.